Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial.

A Belgian ring trial for pan-TRK immunohistochemistry (IHC) staining was organised to harmonise pan-TRK IHC staining protocols and interpretation. As a reference method, the VENTANA pan-TRK Assay (clone EPR17341) on the Benchmark Ultra platform was selected. Six samples were selected: 2 negative, 2 fusion positive and 2 samples with wild-type endogenous TRK expression. Each participating laboratory stained the slides using their routine pan-TRK IHC and reported their results. In addition, they were asked to return one TRK-stained slide from each case. The coordinating lab evaluated these slide... Mehr ...

Verfasser: De Winne, Koen
Sorber, Laure
Lambin, Suzan
Siozopoulou, Vasiliki
Beniuga, Gabriela
Dedeurwaerdere, Franceska
D'Haene, Nicky
Habran, Lionel
Libbrecht, Louis
Van Huysse, Jacques
Weynand, Birgit
Wouters, Katrin
Pauwels, Patrick
Zwaenepoel, Karen
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Verlag/Hrsg.: Springer International
Schlagwörter: Cancer screening / Immunohistochemistry / NTRK fusions / Ring trial / TRK inhibitor
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26526899
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/244699